Fundraising FoxVersant Venture AIV Holdings — 2017 Investments
6 investments dated 2017 · listed companies and verified rows first · show all
Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions.
BiotechHealthtechMedical DevicesIrvine, US
Donald E. Bobo, Jr.(Executive Officer)inScott B. Ullem(Executive Officer)inLarry L. Wood(Executive Officer)inHuimin Wang(Executive Officer)inCatherine M. Szyman(Executive Officer)Bernard Zovighian(Director and Chief Executive Officer)in
Board seatWilliam J. Link· per SEC Form D · $272.4M raise · filed Feb 2017
Co-investorsALIVE Israel HealthTech FundPeregrine Ventures
RxSight is an ophthalmic medical technology company that developed the Light Adjustable Lens (LAL), an intraocular lens that can be customized after cataract surgery to optimize a patient's vision.
HardwareHealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRon Kurtz(Chief Medical Officer (former President & CEO))Mark Wilterding(Chief Financial Officer)in
Board seatWilliam Link· per SEC Form D · $77.5M raise · filed Apr 2017
Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA Capital+2 more
BiotechSan Juan Capistrano, US
Hampar Karageozian(Member of Board of Managers and Chief Executive Officer)inVicken Karageozian(Member of Board of Managers and Chief Technical Officer)inJohn Park(Executive Officer, Director)inMarc D. Kirshbaum(Member of Board of Managers and Chief Operating Officer)in
BoardA. Thomas Bender(Member of Board of Managers)Robert Byrnes(Member of Board of Managers)
Board seatWilliam LinkWilliam J. Link· per SEC Form D · $13.5M raise · filed Jan 2019
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardAli Behbahani(Director)in
Board seatWilliam J Link· per SEC Form D · $43.1M raise · filed Oct 2017
Co-investorsFlying L PartnersNew Enterprise Associates (NEA)Versant VenturesVida Ventures
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)in
BoardJeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Board seatWilliam Link· per SEC Form D · $4.6M raise · filed May 2017
Co-investorsFlying L PartnersVisionary Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.